• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧会推动前列腺肿瘤进展并削弱治疗效果,但也会促进细胞死亡并可作为治疗靶点。

Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target.

作者信息

Rudolfsson Stina Häggström, Bergh Anders

机构信息

Umeå University, Surgical and Perioperative Sciences, Urology and Andrology, NUS, bld 6M, 2 floor Umeå 90185, Sweden.

出版信息

Expert Opin Ther Targets. 2009 Feb;13(2):219-25. doi: 10.1517/14728220802626249.

DOI:10.1517/14728220802626249
PMID:19236239
Abstract

Hypoxia is common in prostate tumours, promoting tumour progression and impairing treatment responses. Hypoxia stimulates angiogenesis but blood vessels formed in tumours are functionally abnormal so the tissue remains hypoxic. Castration treatment is the standard therapy for advanced prostate cancer. In non-malignant prostate tissue castration-induced epithelial cell death is in part mediated by vascular insult and acute hypoxia, but in prostate tumours the cell death response is less prominent and the tumours will eventually relapse. The effect of androgen ablation therapy should therefore be enhanced by additional targeting of the vasculature and hypoxic tumour cells. However if castration fails to kill a sufficiently large number of cells it could by inducing hypoxia make the situation worse. Androgen ablation treatment, may, after the initial vascular insult, result in temporary vascular normalisation and transiently increased tissue oxygen levels. During this time window, which needs to be better defined, the efficacy of cytotoxic drug and radiation treatments are probably enhanced. In order to allow development of more effective treatment strategies for advanced prostate cancer we need to understand the role of hypoxia in prostate cancer progression and treatment responses. With this knowledge we can properly tailor and time additional treatments with androgen ablation.

摘要

缺氧在前列腺肿瘤中很常见,它促进肿瘤进展并损害治疗反应。缺氧刺激血管生成,但肿瘤中形成的血管功能异常,因此组织仍处于缺氧状态。去势治疗是晚期前列腺癌的标准疗法。在非恶性前列腺组织中,去势诱导的上皮细胞死亡部分由血管损伤和急性缺氧介导,但在前列腺肿瘤中,细胞死亡反应不那么明显,肿瘤最终会复发。因此,通过额外靶向脉管系统和缺氧肿瘤细胞,可以增强雄激素剥夺疗法的效果。然而,如果去势不能杀死足够数量的细胞,它可能会通过诱导缺氧使情况变得更糟。雄激素剥夺治疗在最初的血管损伤后,可能会导致暂时的血管正常化和组织氧水平短暂升高。在这个需要更好界定的时间窗内,细胞毒性药物和放射治疗的疗效可能会增强。为了开发更有效的晚期前列腺癌治疗策略,我们需要了解缺氧在前列腺癌进展和治疗反应中的作用。有了这些知识,我们就可以合理地调整雄激素剥夺的额外治疗并确定其时间。

相似文献

1
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target.缺氧会推动前列腺肿瘤进展并削弱治疗效果,但也会促进细胞死亡并可作为治疗靶点。
Expert Opin Ther Targets. 2009 Feb;13(2):219-25. doi: 10.1517/14728220802626249.
2
Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model.靶向去势诱导的肿瘤缺氧增强了去势治疗在大鼠前列腺癌模型中的急性作用。
BJU Int. 2011 Jun;107(11):1818-24. doi: 10.1111/j.1464-410X.2010.09690.x. Epub 2010 Sep 22.
3
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.晚期前列腺癌治疗中早期与延迟雄激素抑制疗法的比较
Cochrane Database Syst Rev. 2002(1):CD003506. doi: 10.1002/14651858.CD003506.
4
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].[欧洲泌尿外科学会前列腺癌指南。第二部分:晚期、复发性及去势抵抗性前列腺癌的治疗]
Actas Urol Esp. 2011 Nov-Dec;35(10):565-79. doi: 10.1016/j.acuro.2011.03.011. Epub 2011 Jul 14.
5
The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.前列腺癌早期去势诱导的原发性肿瘤消退程度不能预测临床结果。
Eur Urol. 2006 Apr;49(4):675-83. doi: 10.1016/j.eururo.2005.10.024. Epub 2005 Dec 19.
6
Endocrine treatment of prostate cancer.前列腺癌的内分泌治疗
J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31.
7
Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.雄激素抑制方法在晚期前列腺癌治疗中的相对有效性和成本效益
Evid Rep Technol Assess (Summ). 1999 May(4):i-x, 1-246, I1-36, passim.
8
Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.在LNCaP前列腺肿瘤异种移植模型中,雄激素剥夺会引发血管变化和缺氧应激,从而促进上皮-间质转化。
Br J Cancer. 2016 Mar 15;114(6):659-68. doi: 10.1038/bjc.2016.29. Epub 2016 Mar 8.
9
Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?晚期前列腺癌的雄激素剥夺治疗:为何会失败,其疗效能否延长?
Can J Urol. 2008 Dec;15(6):4381-7.
10
The biology of hormone refractory prostate cancer. Why does it develop?激素难治性前列腺癌的生物学特性。它为何会发生?
Urol Clin North Am. 1999 May;26(2):263-73. doi: 10.1016/s0094-0143(05)70066-5.

引用本文的文献

1
Hypoxic Signaling Is Modulated by Calcium Channel, CaV1.3, in Androgen-Resistant Prostate Cancer.缺氧信号在雄激素抵抗性前列腺癌中由钙通道CaV1.3调节。
Bioelectricity. 2022 May 26;4(2):81-91. doi: 10.1089/bioe.2022.0007. eCollection 2022 May.
2
Intravoxel incoherent motion and enhanced T2*-weighted angiography for preoperative prediction of microvascular invasion in hepatocellular carcinoma.体素内不相干运动及增强T2*加权血管造影术在肝细胞癌微血管侵犯术前预测中的应用
Front Oncol. 2024 Aug 9;14:1389769. doi: 10.3389/fonc.2024.1389769. eCollection 2024.
3
is essential for xenograft tumor development in mice injected with the human prostate cancer cell-line, LNCaP, and modulates cell migration and invasion.
对于注射了人前列腺癌细胞系LNCaP的小鼠体内异种移植肿瘤的发展至关重要,并调节细胞迁移和侵袭。
J Mens Health. 2022 Feb;18(2). doi: 10.31083/jomh.2021.131. Epub 2021 Oct 14.
4
Aquaglyceroporin-3's Expression and Cellular Localization Is Differentially Modulated by Hypoxia in Prostate Cancer Cell Lines.水甘油通道蛋白-3 的表达和细胞定位受前列腺癌细胞系缺氧的差异调节。
Cells. 2021 Apr 8;10(4):838. doi: 10.3390/cells10040838.
5
Role of opiorphin genes in prostate cancer growth and progression.阿片肽基因在前列腺癌生长和进展中的作用。
Future Oncol. 2021 Jun;17(17):2209-2223. doi: 10.2217/fon-2020-1299. Epub 2021 Feb 17.
6
REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.通过激活自噬信号通路,REST减少对于缺氧诱导的前列腺癌细胞神经内分泌分化至关重要。
Oncotarget. 2016 May 3;7(18):26137-51. doi: 10.18632/oncotarget.8433.
7
Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype.大鼠前列腺肿瘤细胞在骨微环境中进展为高度侵袭性表型。
Neoplasia. 2016 Mar;18(3):152-61. doi: 10.1016/j.neo.2016.01.007.
8
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer.用于前列腺癌低氧微环境可视化的氧气供应图谱。
J Pathol Inform. 2016 Jan 29;7:3. doi: 10.4103/2153-3539.175376. eCollection 2016.
9
Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.在LNCaP前列腺肿瘤异种移植模型中,雄激素剥夺会引发血管变化和缺氧应激,从而促进上皮-间质转化。
Br J Cancer. 2016 Mar 15;114(6):659-68. doi: 10.1038/bjc.2016.29. Epub 2016 Mar 8.
10
High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.非恶性前列腺上皮中高赖氨酸氧化酶(LOX)预示着接受观察等待治疗的前列腺癌患者预后不良。
PLoS One. 2015 Oct 26;10(10):e0140985. doi: 10.1371/journal.pone.0140985. eCollection 2015.